Taro Koba

670 total citations
24 papers, 154 citations indexed

About

Taro Koba is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Physiology. According to data from OpenAlex, Taro Koba has authored 24 papers receiving a total of 154 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Pulmonary and Respiratory Medicine, 7 papers in Oncology and 5 papers in Physiology. Recurrent topics in Taro Koba's work include Lung Cancer Diagnosis and Treatment (6 papers), Lung Cancer Treatments and Mutations (6 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (5 papers). Taro Koba is often cited by papers focused on Lung Cancer Diagnosis and Treatment (6 papers), Lung Cancer Treatments and Mutations (6 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (5 papers). Taro Koba collaborates with scholars based in Japan, United Kingdom and United States. Taro Koba's co-authors include Seigo Minami, Kiyoshi Komuta, Suguru Yamamoto, Takashi Kijima, Masanari Hamaguchi, Yoshitaka Ogata, Hiroshi Kida, Atsushi Kumanogoh, Izumi Nagatomo and Takayuki Takimoto and has published in prestigious journals such as SHILAP Revista de lepidopterología, Medicine and Lung Cancer.

In The Last Decade

Taro Koba

24 papers receiving 149 citations

Peers

Taro Koba
Anastasios Vagionas Greece
Laura Labonté Canada
Machaiah Madhrira United States
Preethi S. Shetty India
Emily S. Andersen United States
Serafeim Chrysikos Greece
Alex Z. Fu United States
Satish Shah United States
Masako Amano Japan
Omar Albanyan United States
Anastasios Vagionas Greece
Taro Koba
Citations per year, relative to Taro Koba Taro Koba (= 1×) peers Anastasios Vagionas

Countries citing papers authored by Taro Koba

Since Specialization
Citations

This map shows the geographic impact of Taro Koba's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Taro Koba with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Taro Koba more than expected).

Fields of papers citing papers by Taro Koba

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Taro Koba. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Taro Koba. The network helps show where Taro Koba may publish in the future.

Co-authorship network of co-authors of Taro Koba

This figure shows the co-authorship network connecting the top 25 collaborators of Taro Koba. A scholar is included among the top collaborators of Taro Koba based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Taro Koba. Taro Koba is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kawasaki, Takahiro, Seigo Kitada, Kiyoharu Fukushima, et al.. (2022). The Diagnosis of Nontuberculous Mycobacterial Pulmonary Disease by Single Bacterial Isolation Plus Anti-GPL-Core IgA Antibody. Microbiology Spectrum. 10(1). e0140621–e0140621. 6 indexed citations
2.
Miki, Keisuke, Ryoji Maekura, Kazuyuki Tsujino, et al.. (2022). Increased Oxygen Extraction by Pulmonary Rehabilitation Improves Exercise Tolerance and Ventilatory Efficiency in Advanced Chronic Obstructive Pulmonary Disease. Journal of Clinical Medicine. 11(4). 963–963. 7 indexed citations
3.
Takimoto, Takayuki, Yu Takeda, Taro Koba, et al.. (2020). MicroRNA Profiles of Serum Extracellular Vesicles in Lymphangioleiomyomatosis. A4971–A4971. 1 indexed citations
4.
Koba, Taro, Yoshito Takeda, Ryohei Narumi, et al.. (2019). Proteomic Profiling of Serum Exosomes to Identify Novel Biomarkers for COPD. A1128–A1128. 1 indexed citations
5.
Takeda, Yutaka, et al.. (2019). Proteomic Profiling of Serum Exosomes to Find Novel Biomarkers in Sarcoidosis. A4489–A4489. 2 indexed citations
6.
Yokoi, Takashi, Seigo Minami, Takayuki Shiroyama, et al.. (2019). A Phase II Study of Tailored-dose S-1 Plus Carboplatin Followed by Maintenance S-1 for Advanced Squamous Cell Lung Cancer: OSAKA-LCSG 1102. Internal Medicine. 58(10). 1405–1410. 4 indexed citations
7.
Koba, Taro, Seigo Minami, Kentaro Masuhiro, et al.. (2018). Phase II trial of induction chemotherapy of pemetrexed plus split-dose cisplatin followed by pemetrexed maintenance for untreated non-squamous non-small-cell lung cancer. Cancer Chemotherapy and Pharmacology. 82(1). 111–117. 2 indexed citations
8.
Koba, Taro, Toru Arai, Masanori Kitaichi, et al.. (2017). Efficacy and safety of transbronchial lung biopsy for the diagnosis of lymphangioleiomyomatosis: A report of 24 consecutive patients. Respirology. 23(3). 331–338. 22 indexed citations
9.
Minami, Seigo, Taro Koba, Motohiro Tamiya, et al.. (2017). Phase II study of S-1 plus bevacizumab combination therapy for patients previously treated for non-squamous non-small cell lung cancer. Cancer Chemotherapy and Pharmacology. 79(6). 1215–1220. 7 indexed citations
10.
Koba, Taro, Takashi Kijima, Takayuki Takimoto, et al.. (2017). Rapid intracranial response to osimertinib, without radiotherapy, in nonsmall cell lung cancer patients harboring the EGFR T790M mutation. Medicine. 96(6). e6087–e6087. 19 indexed citations
11.
12.
Tsuji, Taisuke, et al.. (2017). Systemic Air Embolism Following Diagnostic Bronchoscopy. Internal Medicine. 56(7). 819–821. 7 indexed citations
13.
Nishijima, Yoshinori, et al.. (2015). Influence of indacaterol on daily physical activity in patients with untreated chronic obstructive pulmonary disease. SHILAP Revista de lepidopterología. 2 indexed citations
14.
Minami, Seigo, et al.. (2015). Influence of indacaterol on daily physical activity in patients with untreated chronic obstructive pulmonary disease. International Journal of COPD. 439–439. 10 indexed citations
15.
Fujimoto, Kosuke, Seigo Minami, Suguru Yamamoto, et al.. (2014). Comparison of timing and decision-makers of do-not-resuscitate orders between thoracic cancer and non-cancer respiratory disease patients dying in a Japanese acute care hospital. Supportive Care in Cancer. 22(6). 1485–1492. 12 indexed citations
16.
Minami, Seigo, Takashi Kijima, Takeshi Nakatani, et al.. (2014). Opioid switch from low dose of oral oxycodone to transdermal fentanyl matrix patch for patients with stable thoracic malignancy-related pain. BMC Palliative Care. 13(1). 46–46. 3 indexed citations
17.
Minami, Seigo, Suguru Yamamoto, Yoshitaka Ogata, et al.. (2014). Ambulatory pulse oximetry monitoring in Japanese COPD outpatients not receiving oxygen therapy. Multidisciplinary Respiratory Medicine. 9(1). 24–24. 5 indexed citations
18.
Minami, Seigo, Masanari Hamaguchi, Suguru Yamamoto, et al.. (2014). Small-cell lung cancer: a case report on the manifestation of paraneoplastic motor neuron disease after effective tumor shrinkage during chemotherapy. International Cancer Conference Journal. 3(4). 247–251. 1 indexed citations
19.
20.
Minami, Seigo, Suguru Yamamoto, Yoshitaka Ogata, et al.. (2013). Emergency department visits after hours by lung cancer patients in Japan. Supportive Care in Cancer. 21(9). 2443–2451. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Anastasios Vagionas Breakdown of academic impact, for papers by Laura Labonté Breakdown of academic impact, for papers by Machaiah Madhrira Breakdown of academic impact, for papers by Preethi S. Shetty Breakdown of academic impact, for papers by Emily S. Andersen Breakdown of academic impact, for papers by Serafeim Chrysikos Breakdown of academic impact, for papers by Alex Z. Fu Breakdown of academic impact, for papers by Satish Shah Breakdown of academic impact, for papers by Masako Amano Breakdown of academic impact, for papers by Omar Albanyan
Rankless by CCL
2026